TPT. F. Popova

T. F. Popova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


T. F. Popova has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Current approaches to the diagnosis and treatment of cere - bral venous thrombosis (based on the results of the work of Novosibirsk Regional Vascular Center No. 1)

    by T. F. Popova, I. A. Gribacheva, I. N. Novikova, E. V. Petrova, A. A. Marushchak, M. S. Ponomareva, K. V. Rerikh, D. A. Shashukov

    In clinical practice, cerebral venous disorders are quite rare compared to disorders of arterial origin and account for only 0.5–2.5 %. Understanding the role of congenital and acquired thrombophilia is of particular relevance. With the discovery of new scientific data, it has become clear that many carriers of defective genes remain clinically healthy throughout life, although they are likely to develop this pathology under the influence of constant or temporary risk factors for thrombosis, such as surgery, trauma, estrogens, pregnancy, infections, physical and mental stress, diabetes mellitus, dyslipidemia, etc. Thus, thrombophilia should be discussed not only from a laboratory but also from a clinical perspective. The article analyzes cases of cerebral venous disorders based on data from Regional Vascular Center No. 1 of Novosibirsk.

  • Features of Treatment of Vascular Cognitive Disorders in Patients with Dysphalgia: a Review

    by A.A. Irinchinova, M.S. Ponomareva, L.A. Shchepankevich, I.A. Gribacheva, T.F. Popova, E.V. Petrova

    INTRODUCTION. The risk of developing dementia increases with each decade of life, with vascular etiology accounting for 20%. An aggravating factor is dysphagia, which increases the risk of complications and limits correct therapy. AIM. To summarize current concepts of treating patients with vascular dementia and dysphagia. MATERIALS AND METHODS. In total, more than 100 publications were identified in the PubMed database using the keywords “dysphagia”, “dementia”, “treating” and in the scientific library Elibrary using the keywords “vascular cognitive disorders, dysphagia, treatment”. RESULTS AND DISCUSSION. Swallowing disorders are highly prevalent in older adults with dementia. Dysphagia management includes bolus modification, use of special postures, and rehabilitation interventions. Tableted medications are a major problem, and alternative formulations such as memantine dispersible tablets (Memoritab) are helpful. The ease of administration of this formulation increases patient compliance and provides relief for caregivers. CONCLUSION. The dispersible form of memantine (Memoritab) is an effective and safe alternative to tablet forms of the drug in the treatment of vascular cognitive impairment in patients with dysphagia.

  • Post-stroke cognitive impairment in young patients

    by L.A. Shchepankevich, K.V. Rerikh, I.A. Gribacheva, T.F. Popova, E.V. Taneeva, N.E. Tyazhelnikov, D.V. Sokolova, A.V. Boznyakov

    Objective. To evaluate the effect of Cortexin treatment on cognitive function and quality of life for young patients after ischemic stroke. Material and methods. The open prospective observational study included 30 patients from 18 to 45 years old with confirmed ischemic stroke in the carotid blood supply who received a course of treatment with Cortexin. Before and after therapy, all patients in the study group underwent examination to assess their neuropsychological status (MoCA test), The Short Form-36 (SF-36) questionnaire was used to assess quality of life. The study results were processed using statistical analysis. Results. Based on the results of neurocognitive tests, changes in indicators of neurodynamic, visual-spatial and mnestic functions were determined. Thus, in the beginning of the study the MoCA test scores were 25.1±1.4 points. Over time, there was an improvement mainly in the areas of attention, short-term memory, and multiple aspects of executive functions. However, statistical significance for MoCA was achieved by the end of the second course of treatment with Cortexin (visit 4) — 28.4±1.3 points. Delayed neuropsychological testing showed encouraging results — the achieved level of cognitive functioning was maintained (28.0±1.1). According to SF-36 questionnaire at the stage of inclusion in the observation, low results were noted, which indicated the negative impact of the underlying disease on the daily life of the patient who had suffered a stroke. Low quality of life scores persisted until the third visit; a significant improvement in SF-36 results was recorded at visit 4 and persisted with a positive trend at the fifth visit. Conclusion. Cortexin therapy has been shown to be effective, safe and well tolerated in young people with cognitive deficits in the poststroke period.

  • Open Access

    Clinical experience with the use of citicoline in mild cognitive impairment of vascular origin

    by L. A. Shchepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova, M. S. Shchepankevich

    Cardiovascular factors significantly increase the risk of vascular cognitive impairment (VCI). Currently, there are no specific treatments for VCI. A promising therapeutic strategy is the administration of citicoline, which has a neuroprotective effect.Objective: to evaluate the effect of treatment with citicoline (Noocil®) on cognitive function and quality of life (QoL)in patients with mild cognitive impairment (MCI) developed in a background of arterial hypertension and cerebral arteriosclerosis.Material and methods. An open-label prospective observational study enrolled 32 patients with neuroimaging-confirmed vascular cognitive impairment who received baseline therapy (antihypertensive, lipid-lowering, and antiplatelet therapy) and achieved target blood pressure and low-density lipoprotein cholesterol levels. All patients were assessed with a neuropsychological status assessment (MoCA-test). The efficacy of therapy was assessed by the Short Form-36 Quality of Life Questionnaire (SF-36).Results. The most common complaints of the patients were poor concentration, fatigue, forgetfulness, mood lability, sleep disturbances, more often in the form of early waking, and headaches. After 3 months of taking the drug Noocil®, all patients noted an increase in the ability to work, an improvement in concentration, memory and reproduction of the information received, both physical and mental indicators of QoL improved. The positive dynamics in terms of cognitive status (especially the functions of attention, short-term memory, several aspects of executive functions), QoL of patients, which was associated with the effect of Noocil® therapy, was accompanied by the absence of adverse events. A distinctive feature of domestic citicoline (Noocil®) is the presence of an original dosage form – a 240 ml bottle for oral administration, which improves adherence to long-term therapy.Conclusion. The efficacy, safety and good tolerability of Noocil® therapy in patients with predemental VCI was demonstrated.


  • The role of inflammation in the development of diabetic polyneuropathy and the possibility of its correction

    by L.A. Shchepankevich, M.A. Pervuninskaya, I.A. Gribacheva, T.F. Popova, Yu.A. Nicolaev, E.V. Taneeva, E.V. Petrova, M.S. Shchepankevich

    Objective. To study the effect of the combined drug Cytoflavin on the mechanisms of nonspecific inflammation in the treatment of diabetic polyneuropathy (DPN) with an assessment of the dynamics of the TNF-α index. Material and methods. An open comparative prospective observation of patients with a history of DPN for more than 5 years and a high level of TNF-α was carried out. All patients underwent basic oral combined hypoglycemic therapy, the main group used the combined drug Cytoflavin 10 ml (per 200 ml 0.9% NaCl) for 10 days, followed by the transition to the enteral form of the drug, 2 tablets 2 times a day for 1 months The main indication for the appointment of Cytoflavin was the presence of comorbid pathology in the form of cerebrovascular disease in all studied patients. The severity of clinical symptoms of DPN, the quality of life (QOL) of patients, as well as the dynamics of the level of TNF-α as an indicator reflecting the process of inflammation were assessed. Results. As a result of the treatment in the study group, there was an improvement in QoL, a decrease in the severity of sensory complaints and a decrease in the level of TNF-α, which may indicate a possible anti-inflammatory mechanism of the combined drug Cytoflavin. Conclusion. Cytoflavin can inhibit inflammation and reduce the severity of sensitive disorders in patients with DPN.


  • Open Access

    Mild cognitive impairment treatment issues

    by L. A. Shсhepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova, M. S. Shchepankevich

    Mild cognitive impairment treatment issues


  • Impact of coronavirus infection on asthenic syndrome in patients with ischemic stroke

    by Novosibirsk Sbhi Novosibirsk City Clinical Hospital No. 1, A. A. Marushchak, T. F. Popova, I. A. Gribacheva, E. V. Petrova

    It is known that the presence of asthenic syndrome is characteristic of ischemic brain damage. At the same time, patients with acute cerebral ischemic stroke, who have been diagnosed with a laboratory-confirmed coronavirus infection with a mild and asymptomatic course without signs of damage to other organs, are of particular interest. The aim of the research was to identify and study the severity and duration of asthenic syndrome in patients with ischemic stroke under conditions of the coronavirus infection in order to determine the effect of asthenia on the quality of life in the post-COVID period. The subjects were patients with acute cerebral ischemic stroke with the NIHSS neurological deficit score of 12.0 [9.0;15.0], whose mean age was 58.82±3.29 years [Me=54; Mo=60.0]. The main group (38 people) included patients with laboratory-confirmed coronavirus infection without signs of damage to other organs; the comparison group (31 people) consisted of patients with AMI only, comparable to the main group in all respects, including the set of vascular risk factors. All patients underwent a clinical and neurological examination, an examination by a general practitioner and / or a cardiologist, CT using an angio mode, the MFI-20 questionnaire, A. M. Wein questionnaire, Spielberger and Khanin scale. Quality of life was assessed using a short version of the MOS SF-36‑ltem questionnaire. Statistical analysis of the obtained results was carried out via statistical programs Microsoft Office Excel 2007 (USA) and Statistica for Windows, v. 10.0. It has been established that the coronavirus infection aggravates the course of asthenic syndrome in patients with acute ischemic stroke, has a long-term effect on the recovery process, remains relevant in the post-COVID period, and is accompanied by anxiety and vegetative disorders. Organic symptomatic asthenia largely determines the course of the pathological process, affecting the general condition, performance, social adaptation and, as a result, the quality of life of the patient.

  • Open Access

    THE ROLE OF DISPOSITION OF CONNECTING TISSUE IN THE RISE OF NONTRAUMATIC SUBARACHNOIDAL HEMORRHAGE IN YOUNG AGE

    by E. V. Petrova, T. F. Popova, I. A. Gribacheva, G. K. Taitubayeva

    Purpose. To identify possible effects of systemic dysmorphogenesis of connective tissue on the formation and characteristics of the course of nontraumatic subarachnoid hemorrhage at a young age, with further development of an algorithm for screening physical examination of patients with an increased risk of aneurysmal hemorrhage.Patients and methods. A group of examined patients who underwent SAH under the age of 45 years were 78 people. Methods: neurological examination according to a conventional scheme using traditional methods with assessment of the main functional systems and determining the depth of their damage, determination of constitutional types, assessment of the degree of phenotypic manifestation of DCT by the sum of scores, general clinical laboratory, neuroimaging, and statistical.In order to determine the signs of connective tissue pathology in all patients with SAH, the general examination included determining the constitution, height, weight with the definition of the Ketle index. Attention was also paid to the presence of visible small vessels on the face, chest and other parts of the body, telangiectasias, angiomas, thoracic cell deformities, scoliosis, flat feet, arachnodactyly, diastase of the rectus abdominis muscles, hernia of the anterior abdominal wall. Among the many undifferentiated phenotypic signs of DCT, external (changes in the skin and its derivatives, changes in bones, joints, spine, features of the structure of the hands and feet, peculiarities of the structure of the auricle, eyes, oral cavity, craniocephalic features) and internal (the presence of additional chords, heart valve prolapses, nephroptosis and kidney development abnormalities).Results. When examining 78 patients with subarachnoid hemorrhage at a young age, the risk factors for its development were revealed (non-closed Willisian circle (86.6%), pathological tortuosity of the cerebral vessels (81.6%), dysplastic changes in the heart (68.3%) and kidneys (63.3%), which significantly differed from the comparison group (arterial hypertension – 97.8%, heart disease (IHD, atrial fibrillation) – 53.2%, hypercholesterolemia – 97.8%.) The value of systemic dysplastic change in connective tissue in the formation and flow of SAC at young age is shown. The constitutional-anatomical and functional features, characteristic for external and internal phenotypic signs of connective tissue dysplasia in different age groups, are revealed, and the role of additional vascular risk factors in the course of SAH are found. Conclusion. The complex study of connective tissue dysplasia as a risk factor for the development of aneurysms with a clinical manifestation in the form of SAH at a young age can be used in clinical practice for the timely detection and surgical treatment of aneurysms without signs of SAH. The obtained data can become a basis for developing an algorithm for screening physical examination of patients with an increased risk of aneurysmal hemorrhage.


  • Open Access

    STROKE AND PREGNANCY: THE MAIN RISK FACTORS

    by G. K. Taitubayeva, I. A. Gribacheva, E. V. Petrova, Т. F. Popova

    ИНСУЛЬТ И БЕРЕМЕННОСТЬ: ОСНОВНЫЕ ФАКТОРЫ РИСКА